Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPH
1201
DELISTED
Tri Pointe Homes
TPH
| $6.75M | 0.01% |
441,336
+169,897
| +63% | +$2.53M |
|
|
PRAH
1202
DELISTED
PRA Health Sciences, Inc.
PRAH
| $6.75M | 0.01% |
185,731
-795,199
| -81% | -$25.2M |
|
|
OPB
1203
DELISTED
Opus Bank Common Stock
OPB
| $6.74M | 0.01% |
186,220
+300
| +0.2% | +$9.69K |
|
1204
ABM Industries
ABM
$2.73B
| $6.74M | 0.01% |
204,892
+37,320
| +22% | +$1.21M |
|
1205
State Street SPDR S&P Retail ETF
XRT
$325M
| $6.73M | 0.01% |
136,494
-65,308
| -32% | -$3.25M |
|
|
VIVO
1206
DELISTED
Meridian Bioscience Inc
VIVO
| $6.72M | 0.01% |
360,568
-107,889
| -23% | -$2M |
|
1207
Piper Sandler
PIPR
$5.26B
| $6.71M | 0.01% |
614,792
+535,724
| +678% | +$6.69M |
|
1208
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
| $6.67M | 0.01% |
144,985
-360
| -0.2% | -$17.6K |
|
1209
Murphy USA
MUSA
$10B
| $6.66M | 0.01% |
119,336
-43,047
| -27% | -$2.7M |
|
|
CEMP
1210
DELISTED
Cempra, Inc.
CEMP
| $6.66M | 0.01% |
193,776
+111,776
| +136% | +$3.95M |
|
|
RTI
1211
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $6.63M | 0.01% |
210,206
-241,260
| -53% | -$8.75M |
|
1212
Dana Inc
DAN
$3.23B
| $6.62M | 0.01% |
+321,765
| New | +$6.96M |
|
1213
Metallus
MTUS
$793M
| $6.62M | 0.01% |
245,238
+168,111
| +218% | +$4.96M |
|
|
SYA
1214
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $6.61M | 0.01% |
273,615
-10,306
| -4% | -$251K |
|
|
CCC
1215
DELISTED
Calgon Carbon Corp
CCC
| $6.6M | 0.01% |
340,779
-117,970
| -26% | -$2.53M |
|
1216
Teekay
TK
$1.16B
| $6.52M | 0.01% |
+152,348
| New | +$7.21M |
|
|
SVC
1217
Service Properties Trust
SVC
$1.04B
| $6.52M | 0.01% |
45,587
-23,363
| -34% | -$3.55M |
|
|
FSL
1218
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $6.52M | 0.01% |
163,114
-409,896
| -72% | -$17M |
|
1219
Smith & Wesson
SWBI
$608M
| $6.51M | 0.01% |
510,944
+101,731
| +25% | +$1.17M |
|
1220
Green Brick Partners
GRBK
$3.11B
| $6.49M | 0.01% |
+592,570
| New | +$5.49M |
|
1221
Adeia
ADEA
$2.93B
| $6.48M | 0.01% |
645,027
+574,099
| +809% | +$5.89M |
|
|
FCAM
1222
DELISTED
Fiat Chrysler Automobiles N.V.
FCAM
| $6.48M | 0.01% |
50,000
| – | – |
|
1223
MaxLinear
MXL
$5.93B
| $6.46M | 0.01% |
533,837
+432,316
| +426% | +$4.34M |
|
1224
Novavax
NVAX
$1.56B
| $6.46M | 0.01% |
28,975
+13,628
| +89% | +$2.4M |
|
|
DOOR
1225
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $6.45M | 0.01% |
91,970
+74,014
| +412% | +$5.08M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.